As a consequence, reduced levels of full-length SMN protein produced from the SMN2 gene, while sufficient to prevent embryonic lethality, are not able to fully compensate for the loss of SMN1 resulting in motor neuron disease. This evidence concerns the gene SMN2 and motor neuron disorder.